CUI JINGRONG JEAN (Chief Scientific Officer) sold 3.9% of their position (31.79K shares) of TURNING POINT THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.37M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−900.00
Price / share
$36.52
Trade value
$32.87K
% of position
Common Stock
Shares
−1.90K
Price / share
$37.88
Trade value
$71.97K
% of position
Common Stock
Shares
−3K
Price / share
$38.77
Trade value
$116.31K
% of position
Common Stock
Shares
−1.20K
Price / share
$39.63
Trade value
$47.56K
% of position
Common Stock
Shares
−1.30K
Price / share
$40.75
Trade value
$52.98K
% of position
Common Stock
Shares
−3.20K
Price / share
$41.73
Trade value
$133.54K
% of position
Common Stock
Shares
−2.10K
Price / share
$42.72
Trade value
$89.71K
% of position
Common Stock
Shares
−400.00
Price / share
$43.58
Trade value
$17.43K
% of position
Common Stock
Shares
−2.10K
Price / share
$44.56
Trade value
$93.58K
% of position
Common Stock
Shares
−13.29K
Price / share
$45.35
Trade value
$602.79K
% of position
Common Stock
Shares
−2.20K
Price / share
$46.50
Trade value
$102.30K
% of position
Common Stock
Shares
−200.00
Price / share
$47.11
Trade value
$9.42K
% of position
Net shares
−31.79K
Net value
-$1.37M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/23/2020 | S · Sale | −900.00 | $36.52 | $32.87K | 0.1% | 825.38K | 824.48K |
| Common Stock Indirect | 3/23/2020 | S · Sale | −1.90K | $37.88 | $71.97K | 0.2% | 824.48K | 822.58K |
| Common Stock Indirect | 3/23/2020 | S · Sale | −3K | $38.77 | $116.31K | 0.4% | 822.58K | 819.58K |
| Common Stock Indirect | 3/23/2020 | S · Sale | −1.20K | $39.63 | $47.56K | 0.1% | 819.58K | 818.38K |
| Common Stock Indirect | 3/24/2020 | S · Sale | −1.30K | $40.75 | $52.98K | 0.2% | 818.38K | 817.08K |
| Common Stock Indirect | 3/24/2020 | S · Sale | −3.20K | $41.73 | $133.54K | 0.4% | 817.08K | 813.88K |
| Common Stock Indirect | 3/24/2020 | S · Sale | −2.10K | $42.72 | $89.71K | 0.3% | 813.88K | 811.78K |
| Common Stock Indirect | 3/24/2020 | S · Sale | −400.00 | $43.58 | $17.43K | 0.0% | 811.78K | 811.38K |
| Common Stock Indirect | 3/25/2020 | S · Sale | −2.10K | $44.56 | $93.58K | 0.3% | 811.38K | 809.28K |
| Common Stock Indirect | 3/25/2020 | S · Sale | −13.29K | $45.35 | $602.79K | 1.6% | 809.28K | 795.99K |
| Common Stock Indirect | 3/25/2020 | S · Sale | −2.20K | $46.50 | $102.30K | 0.3% | 795.99K | 793.79K |
| Common Stock Indirect | 3/25/2020 | S · Sale | −200.00 | $47.11 | $9.42K | 0.0% | 793.79K | 793.59K |
| Total | −31.79K | -$1.37M | ||||||
Common Stock
DirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1M | Direct |
| Common Stock | 300K | Indirect |
| Total | 1.30M | 1M direct·300K indirect |